- Home
- ABBV vs UBS Comparison
ABBV vs UBS Comparison
Compare ABBV & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABBV | UBS |
|---|---|---|
| Founded | 2012 | 1862 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5B | 154.1B |
| IPO Year | 2012 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ABBV | UBS |
|---|---|---|
| Price | $233.37 | $49.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 2 |
| Target Price | ★ $253.71 | $60.30 |
| AVG Volume (30 Days) | ★ 3.9M | 2.2M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.39% | 1.29% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $61,160,000,000.00 | N/A |
| Revenue This Year | $11.87 | $7.40 |
| Revenue Next Year | $8.12 | $2.83 |
| P/E Ratio | $601.87 | ★ $17.22 |
| Revenue Growth | ★ 8.57 | N/A |
| 52 Week Low | $181.75 | $32.69 |
| 52 Week High | $244.81 | $51.24 |
Technical Indicators
Market Signals| Indicator | ABBV | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 62.86 | 57.56 |
| Support Level | $220.11 | $46.47 |
| Resistance Level | $237.81 | N/A |
| Average True Range (ATR) | 5.28 | 0.81 |
| MACD | 0.69 | 0.04 |
| Stochastic Oscillator | 80.13 | 59.87 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About UBS UBS Group AG Registered
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.